Niagen Bioscience (NAGE) Total Liabilities (2011 - 2026)

Niagen Bioscience (NAGE) has 15 years of Total Liabilities data on file, last reported at $32.0 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $32.0 million, up 23.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.0 million (up 23.11% YoY), and the FY2025 annual result was $29.9 million, up 34.66% from the prior year.
• Total Liabilities climbed to $32.0 million in Q1 2026 per NAGE's latest filing, from $29.9 million in the prior quarter.
• Over five years, Total Liabilities peaked at $32.0 million in Q1 2026 and troughed at $22.2 million in Q3 2024.
• A 5-year average of $26.0 million and a median of $26.0 million in 2025 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 161.72% in 2022, then fell 16.31% in 2024.
• A 5-year view of Total Liabilities shows it stood at $25.4 million in 2022, then advanced by 4.42% to $26.5 million in 2023, then slipped by 16.31% to $22.2 million in 2024, then surged by 34.66% to $29.9 million in 2025, then grew by 7.12% to $32.0 million in 2026.
• Business Quant data shows NAGE's Total Liabilities at $32.0 million in Q1 2026, $29.9 million in Q4 2025, and $27.5 million in Q3 2025.